Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women

Archives of Pediatrics and Adolescent Medicine

Volumn 160, Issue 2, 2006, Pages 151-156

  Shew, Marcia L ^a   Fortenberry, J Dennis ^a   Tu, Wanzhu ^a   Juliar, Beth E ^a   Batteiger, Byron E ^a   Qadadri, Brahim ^a   Brown, Darron R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; ADOLESCENT; ARTICLE; CHLAMYDIA TRACHOMATIS; CITY; CLINICAL ARTICLE; CONDOM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; NEISSERIA GONORRHOEAE; ONCOGENE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; UNITED STATES; VERRUCA VULGARIS; WART VIRUS;

ADOLESCENT; CONDOMS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; LONGITUDINAL STUDIES; MULTIVARIATE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; TIME FACTORS;

EID: 32244441155     PISSN: 10724710     EISSN: 10724710     Source Type: Journal    
DOI: 10.1001/archpedi.160.2.151     Document Type: Article

References (38)

1. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003; 16:1-17.
2. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J Infect Dis. 2002;186:462-469.
3. Ho GYF, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-428.
4. Brown DR, Shew ML, Qadadri B, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191:182-192.
5. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001;286: 3106-3114.
6. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132:277-284.
7. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev. 2003;12:485-490.
8. Elfgren K, Kalantari M, Moberger B, Bjorn H, Dillner J. A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol. 2000;183:561-567.
9. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 2002;94:1406-1414.
10. Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer. 2000;83: 1565-1572.
11. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001;285:2995-3002.
12. Giulian AR, Sedjo RL, Roe DJ, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control. 2002;13:839-846.
13. Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184:682-690.
14. Brisson J, Bairati I, Morin C, et al. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis. 1996;173:794-799.
15. Smith JS, Munoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis. 2002;185:324-331.
16. Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001;285: 47-51.
17. Wallin KL, Wiklund F, Luostarinen T, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical cancer. Int J Cancer. 2002; 101:371-374.
18. Tarkowski TA, Koumans EH, Sayer M, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis. 2004;189:46-50.
19. Wright TC Jr, Denny L, Kuhn L, Pullack A, Lorizncz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283:81-86.
20. Gravitt PE, Lacey JV, Brinton LA, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev. 2001;10:95-100.
21. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-361.
22. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36:3020-3027.
23. Brown DR, Legge D, Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted disease clinic. Sex Transm Dis. 2002;29:763-768.
24. Kengne P, Veas F, Vidal N, Rey NL, Cuny G. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol. 1994;40:819-831.
25. Palmer HM, Mallinson H, Woods RL, Herring AJ. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J Clin Microbiol. 2003;41:835-837.
26. Farrell DJ. Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. J Clin Microbiol. 1999;37:386-390.
27. Ho BS, Feng WG, Wong BK, Egglestone SI. Polymerase chain reaction for the detection of Neisseria gonorrhoeae in clinical samples. J Clin Pathol. 1992; 45:439-442.
28. Thereau T, Grambsch P. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer; 2002.
29. 1998 Guidelines for treatment of sexually transmitted diseases: Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47:1-111.
30. Castle PE, Guiliano AR. Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr. 2003;31:29-34.
31. Robertson SA, Sharkey DJ. The role of semen in induction of maternal immune tolerance to pregnancy. Semin Immunol. 2001;13:243-254.
32. Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer. 2003;107:811-816.
33. Zhang ZF, Graham S, Yu SZ, et al. Trichomonas vaginalis and cervical cancer: a prospective study in China. Ann Epidemiol. 1995;5:325-332.
34. Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111:431-439.
35. Clerici M, Merola M, Ferrario E, et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst. 1997;89:245-250.
36. Castellsague X, Munoz N. Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20-28.
37. Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. Incident chlamydia trachomatis infections among inner-city adolescent females. JAMA. 1998;280:521-526.
38. Orr DP, Fortenberry JD, Blythe MJ. Validity of self-reported sexual behaviors in adolescent women using biomarker outcomes. Sex Transm Dis. 1997;24: 261-266.